Cancer-fighting Peninsula company postpones $92 million IPO By: San Francisco Business Times via Business Journals August 01, 2019 at 15:06 PM EDT The company has planned for the IPO proceeds to fund clinical trials in experimental cancer and inflammation drugs. Read More >>